trending Market Intelligence /marketintelligence/en/news-insights/trending/6gd0p72swwu2dljpnjub-q2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

NeuroMetrix prices $26.5M offering

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


NeuroMetrix prices $26.5M offering

NeuroMetrix Inc. priced a public offering to raise $26.5 million in gross proceeds.

The offering was priced at 70 cents per common share, with each share sold with 1 warrant to purchase 1 common share. The warrants are exercisable at a price of 70 cents per common share immediately upon issuance and will expire five years after issuance.

NeuroMetrix will use about $19.45 million of the proceeds to redeem about 19,450 series D convertible preferred shares and retire about 23.5 million warrants to buy outstanding common stock. The company will use the remaining proceeds to fund the commercialization of Quell, its over-the-counter wearable device for relief of chronic pain, in the U.S. and for general corporate purposes.

The offering is expected to close Dec. 23, subject to customary closing conditions.

Rodman & Renshaw is the offering's exclusive placement agent.